Featured Publications

Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2

Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2

Liu Q, Oesterlund EJ, Chi X, Pogmore J, Leber B, Andrews D.W., Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2. (2019). Elife. 8:e37689. doi: 10.7554/eLife.37689.

Read More

Bcl-XL inhibits membrane permeabilization by competing with Bax

Bcl-XL inhibits membrane permeabilization by competing with Bax

Billen L.P., Kokoski C.L., Lovell J.F., Leber, B., and Andrews, D.W., Bcl-XL inhibits membrane permeabilization by competing with Bax. (2008) PLoS Biol 6(6): e147. [Featured in a mini-review in the same issue and in Research Highlights, Nature Immunology, August 2008, 9:837; Faculty 1000 Biology: http://www.f1000biology.com/article/id/1123833/evaluation].

Read More

Differences in the mechanisms of proapoptotic BH3 proteins binding to Bcl-XL and Bcl-2 quantified in live MCF-7 cells

Differences in the mechanisms of proapoptotic BH3 proteins binding to Bcl-XL and Bcl-2 quantified in live MCF-7 cells

Aranovich, A., Liu, Q., Collins, T.J., Geng F., Dixit S., Leber B., and Andrews, D.W., Differences in the mechanisms of proapoptotic BH3 proteins binding to Bcl-XL and Bcl-2 quantified in live MCF-7 cells. (2012) Mol Cell., 45:754-63.

Read More

Mechanisms of action of Bcl-2 family proteins

Mechanisms of action of Bcl-2 family proteins

Shamas-Din A., Kale J., Leber B., and Andrews, D.W., Mechanisms of action of Bcl-2 family proteins. (2013) Cold Spring Harbor Perspectives In Biology, 5(4):a008714. (Review)

Read More

High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells

High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells

Oppermann S., Ylanko J., Shi Y., Hariharan S., Oakes C.C., Brauer P.M., Zuniga-Pflucker J.C., Leber B., Spaner D.E., and Andrews, D.W., High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells. (2016) Blood. 128(7):934-947. doi: 10.1182/blood-2015-12-687814.

Read More

A small-molecule inhibitor of Bax and Bak oligomerization prevents genotoxic cell death and promotes neuroprotection

A small-molecule inhibitor of Bax and Bak oligomerization prevents genotoxic cell death and promotes neuroprotection

Niu X., Brahmbhatt H., Mergenthaler P., Zhang Z., Sang J., Daude M., Ehlert F.G.R., Diederich W.E., Wong E., Zhu W., Pogmore J.P, Nandy J.P., Satyanarayana M., Jimmidi R.K., Arya P., Leber B., Lin J., Culmsee C., Yi J., and Andrews, D.W., A small molecule inhibitor of both proapoptotic Bax and Bak oligomerization prevents genotoxic cell death and promotes neuroprotection.(2017) Cell Chemical Biology.24(4):493-506.e5. doi: 10.1016/j.chenbiol.2017.03.011.

Read More